Investment strategy sees Crawford Healthcare quadruple production

Wound care company Crawford Healthcare has quadrupled its manufacturing capabilities after investing in its Cheshire production facility.

The Knutsford-based firm, which was last month ranked as the fifth biggest wound care company in the UK, said the expansion at its Tarvin facility will enable it to produce up to 40m wound dressings every year.

Furthermore, Crawford Healthcare claimed the investment would boost its North West footprint by 25%.

Crawford Healthcare’s CEO, Richard Anderson, said: “This latest development in Crawford Healthcare’s continued expansion is evidence of our growth strategy in action, as we look to roll out our offering globally.

“Our US division is maturing as anticipated, alongside our more fledgling operation in Germany and the EU, which is why we have taken the decision to invest heavily for the future.”

He added: “While the expansion will initially serve our progress in these markets, the investment has been factored into our long-term strategy which will see us develop a much wider international reach.”